On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...

The high court overturned a ruling that the FDA arbitrarily banned e-cigarette products.

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up Hikma’s appeal of the U.S. Court of Appeals for the Federal Circuit’s ruling ...

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...

DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...

A systematic review found that FDA leaders historically accepted recommendations made by the agency’s scientists regarding mifepristone.

The case centered on venue-shopping and whether the tobacco company R.J. Reynolds could appeal in the 5th Circuit appeals court, far from its headquarters.

The Trump administration has asked a federal court to pause Louisiana's lawsuit challenging the mailing of the abortion drug ...

January would have marked the 53rd anniversary of Roe v. Wade, the 1973 Supreme Court decision that legalized abortion ...